Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Lactobacillus rhamnosus GG protects against atherosclerosis by improving ketone body synthesis. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 106 Issue 24 Pages: 8233-8243 Pub: 2022 Dec Epub: 2022 Nov 17 Authors Zhai T , Ren W , Wang P , Zheng L , |
|
|
Effects of Dietary Oregano Essential Oil on Cecal Microorganisms and Muscle Fatty Acids of Luhua Chickens. β
Go to Publication β
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 12 Issue 22 Pages: Pub: 2022 Nov 20 Epub: 2022 Nov 20 Authors Wu T , Yang F , Jiao T , Zhao S , |
|
|
Antimicrobial Activity of Five Essential Oils against Bacteria and Fungi Responsible for Urinary Tract Infections. β
Go to Publication β
Molecules (Basel, Switzerland) (Molecules ) Vol: 23 Issue 7 Pages: Pub: 2018 Jul 9 Epub: 2018 Jul 9 Authors Ebani VV , Nardoni S , Bertelloni F , Pistelli L , Mancianti F , |
|
|
Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for Candida albicans Infections. β
Go to Publication β
ACS applied materials & interfaces (ACS Appl Mater Interfaces ) Vol: 16 Issue 31 Pages: 40628-40640 Pub: 2024 Aug 7 Epub: 2024 Jul 27 Authors Fernandes L , Barco-Tejada A , Blázquez E , Araújo D , Ribeiro A , Silva S , Cussó L , Costa-de-Oliveira S , Rodrigues ME , Henriques M , |
|
|
Salivary pH Modulation and Antimicrobial Properties of Oregano-Oil Jelly in Relation to Menstrual and Menopausal Status. β
Go to Publication β
Nutrients (Nutrients ) Vol: 17 Issue 15 Pages: Pub: 2025 Jul 29 Epub: 2025 Jul 29 Authors Potra Cicalau GI , Ciavoi G , Scrobota I , Venter ID , Ganea MF , Ghitea MC , Ghitea EC , Gîtea MF , Ghitea TC , Nagy C , Pelea DC , Dobjanschi L , Gligor O , Moisa C , Ganea M , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
